Mahindra Manulife
Large Cap Fund


(Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks)
Note: Mahindra Manulife Large Cap Pragati Yojana scheme has been renamed as Mahindra Manulife Large Cap Fund w.e.f. March 1, 2023



One Pager as on February 28, 2023

 
Agile quality portfolio from India's Big 100 Companies*
 
Exposure to the more stable half of the market
 
High conviction bottom up stock picking with a focus on alpha generation
 
*In terms of Full Market Capitalisation.
  • A concentrated portfolio of market leaders and established businesses.

  • A portfolio with measured exposure in other market caps for possible alpha generation.
  • Key Overweight sector/Industries includes Banks, Industrials and IT. Reduced Overweight in insurance post Union Budget announcements

  • Key Underweights sectors /Industries includes Finance and Oil & gas vs the Scheme’s Benchmark. Selectively added weight to Oil & Gas based on bottom up ideation

  • Portfolio has majority allocation towards large caps with very marginal exposure to mid and small caps currently. However, we continue to evaluate bottom up opportunities in the space

Data as on February 28, 2023

Sector MMLCF Nifty 100 Index TRI
Financial Services 35.07% 35.00%
Information Technology 15.83% 13.50%
Oil Gas & Consumable Fuels 8.86% 11.54%
Fast Moving Consumer Goods 8.71% 9.79%
Automobile And Auto Components 6.89% 5.22%

Data as on February 28, 2023

Security % to Net Assets
HDFC Bank Limited 9.53%
ICICI Bank Limited 9.17%
Reliance Industries Limited 7.34%
Infosys Limited 7.04%
Tata Consultancy Services Limited 5.92%
Larsen & Toubro Limited 4.18%
State Bank of India 4.17%
Axis Bank Limited 3.97%
Maruti Suzuki India Limited 3.86%
Hindustan Unilever Limited 2.98%
Total 58.15%
Fresh Additions Complete Exits
Security Security
GAIL (India) Limited Ambuja Cements Limited
Housing Development Finance Corporation Limited APL Apollo Tubes Limited
UltraTech Cement Limited HCL Technologies Limited
Life Insurance Corporation Of India
Piramal Pharma Limited
Siemens Limited


Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on February 28, 2023

Turnover Ratio (Last 1 year) 1.11
Standard Deviation 20.29%
Beta1 0.88
Sharpe Ratio# 0.46
Jenson's Alpha2 -0.0377


#Risk-free rate assumed to be 6.70% (MIBOR as on 28-02-23) - Source: www.mmda.org
1. Beta is calculated on the basis of average monthly rolling returns as of last day of the month since inception till February 28, 2023 and annualized. 2. Calculated for the period since inception till February 28, 2023. | Data Source: ICRA Analytics, Bloomberg | Data as on February 28, 2023

Investment Objective:
The investment objective of the Scheme is to provide long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in large cap companies. However, there can be no assurance that the investment objective of the Scheme will be achieved.

Fund Manager:

Mr. Abhinav Khandelwal
Total Experience : 14 years
Experience in managing this fund: 1 Year (Managing since March 1, 2022)

Ms. Fatema Pacha
Total Experience : 17 years,
Experience in managing this fund: 2 years and 2 month (Managing since December 21, 2020)

Date of allotment: March 15, 2019

Benchmark: Nifty 100 Index TRI

Option: IDCW (IDCW Option will have IDCW Reinvestment (D) & IDCW Payout facility) and Growth (D)
D-Default

Application Amount: Rs. 1,000 and in multiples of Re. 1/- thereafter

Additional Purchase Amount: Rs. 1,000 and in multiples of Re. 1/- thereafter

Minimum Weekly & Monthly SIP Amount: Rs 500 and in multiples of Re.1/- thereafter

Minimum Weekly & Monthly SIP Installments: 6

Minimum Quarterly SIP Amount: Rs 1,500 and in multiples of Re. 1/- thereafter

Minimum Quarterly SIP installments: 4

Minimum Amount for Switch in: Rs. 1,000/- and in multiples of Re. 0.01/- thereafter.

Minimum Amount for Redemption / Switch-outs: Rs. 1,000/- or 100 units or account balance, whichever is lower in respect of each Option.

Monthly AAUM as on February 28, 2023 (Rs. in Cr.): 220.27

Monthly AUM as on February 28, 2023 (Rs. In Cr.): 215.81

Entry Load: Not applicable

Exit Load: • An Exit Load of 1% is payable if Units are redeemed / switched-out upto 1 year from the date of allotment

• Nil if Units are redeemed / switched-out after 1 year from the date of allotment.

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Abhinav Khandelwal is managing this scheme since March 1, 2022. Ms. Fatema Pacha is managing this scheme since December 21, 2020. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).

^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Abhinav Khandelwal manages 6 schemes and Ms. Fatema Pacha manages 9 schemes of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on February 28, 2023.

Scheme Name
Mahindra Manulife Large Cap Fund

This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment predominantly in equity and equity related securities including derivatives of large cap companies.

Scheme Riskometer

Scheme Benchmark
Nifty 100 Index TRI

Benchmark Riskometer

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Investment Management Private Limited nor Mahindra Manulife Trustee Private Limited, its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Get in Touch: Sadhana House, 1st Floor, 570,
P.B. Marg, Worli, Mumbai - 400 018, India.
Phone: +91-22-66327900, Fax: +91-22-66327932
Toll Free No.: 1800 419 6244
Website: www.mahindramanulife.com

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
CNo.01293